Inicio › Linfoma de Burkitt › Illinois › Chicago
Ensayos clínicos de Linfoma de Burkitt en Chicago, IL
15 estudios para Linfoma de Burkitt buscan participantes en centros de Chicago y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
ReclutandoFase 1/2
- Research Site, Chicago
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
ReclutandoFase 1
- Lurie Children's Hospital, Chicago
Asciminib and Inotuzumab Ozogamicin for Relapsed or Refractory Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (R/R Ph+ B-ALL)
ReclutandoFase 1
- University of Chicago Comprehensive Cancer Center, Chicago
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
ReclutandoFase 2
- Northwestern University, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
ReclutandoFase 2
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
ReclutandoFase 3
- Northwestern University, Chicago
- Rush MD Anderson Cancer Center, Chicago
- University of Illinois, Chicago
- y 1 más
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
ReclutandoFase 2
- Lurie Children's Hospital-Chicago, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
ReclutandoFase 2
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
ReclutandoFase 1/2
- Research Site, Chicago
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
ReclutandoFase 2
- University of Chicago Comprehensive Cancer Center, Chicago
Blinatumomab Consolidation in Real World
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Northwestern University, Chicago
- The University of Chicago, Chicago
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
ReclutandoFase 3
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
ReclutandoFase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
ReclutandoFase 1
- University of Chicago Comprehensive Cancer Center, Chicago
Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)
Reclutando
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Ensayos de Linfoma de Burkitt en otras ciudades
- Houston, TX20 estudios
- Milwaukee, WI16 estudios
- Philadelphia, PA15 estudios
- Seattle, WA14 estudios
- Atlanta, GA13 estudios
- New York City, NY13 estudios
- Cincinnati, OH13 estudios
- Los Angeles, CA10 estudios
- Baldwin Park, CA10 estudios
- Aurora, CO10 estudios
- Durham, NC10 estudios
- Kansas City, MO10 estudios
Otros estudios en Chicago
- Cáncer de seno59 estudios
- Cáncer de pulmón de células no pequeñas59 estudios
- Cáncer (todos los tipos)51 estudios
- Cáncer de próstata45 estudios
- Cáncer de pulmón43 estudios
- Cáncer metastásico42 estudios
- Obesidad40 estudios
- Cáncer de ovario36 estudios
- Cáncer del colon y del recto32 estudios
- Accidente cerebrovascular31 estudios
- Carcinoma de células escamosas de cabeza y cuello29 estudios
- Sobrepeso29 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.